Study Group: Affymetrix and Illumina SNP Chips Users (US)(?)
Council Members in this Study Group: 26
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Leading Experts in this Study Group
![]() |
What is a GLG Leader? |
Gregory Khitrov, PhDDirector of Personalized Medicine Program
MOUNT SINAI SCHOOL OF MEDICINE
Greg Khitrov, PhD, is the Director of Life Sciences Technology Center at the Institute for Personalized Medicine, Director of Biobank and an Assistant Professor of Medicine at the Mount Sinai School of Medicine in New York. He has expertise in molecular biology; proteomics; and laboratory automation...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Illumina's SNP Chip Users (US) | 35 |
| Affymetrix 500K SNP Chip Users (US) | 50 |
| Affymetrix Gene Chip Users | 72 |
| Solexa Genome Analysis System Users | 27 |
| Applied Biosystems' SOLiD System Users | 17 |
| Oncologists (US) | 2254 |
GLG InstituteSM
Seminars with this Study Group's Leaders(?)
Recent Seminars
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
- Research Foundation
- Medical Equipment & Supplies Manufacturer
- Office Based Private Practice or Clinic
- Pharmaceuticals Manufacturer
Most Common Job Types:
- Physician - Attending Physician
- Director
- Research Scientist
- Professor
- Physician - Director
- Physician - Department Chair
- Researcher
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate


